• Medical News

    World Chronic Hand Eczema Day to Launch October 5

  • Medical News

    Dr. Alexa Kimball Highlights Early Response, HiSCR75 Findings With Tulisokibart in Hidradenitis Suppurativa

  • Medical News

    Sun Pharma Reports 2-Year Deuruxolitinib Data in Severe Alopecia Areata

advertisement
advertisement

Programs

  • Face Value with Modern Aesthetics: The Good and the Bad of Artificial Intellige…
    Modern Aesthetics

    Face Value with Modern Aesthetics: The Good and the Bad of Artificial Intelligence in Aesthetics

  • Recognizing Loss of Treatment Response in Psoriatic Arthritis
    Living Rheum

    Recognizing Loss of Treatment Response in Psoriatic Arthritis

  • Improving Psoriatic Arthritis Diagnosis: The Role of Education
    Living Rheum

    Improving Psoriatic Arthritis Diagnosis: The Role of Education

  • Defining Meaningful Response in Hidradenitis Suppurativa
    On the Frontlines of Hidradenitis Suppurativa

    Defining Meaningful Response in Hidradenitis Suppurativa

  • Sotatercept in PAH: Safety Signals from Real-World Data
    Clinician's Roundtable

    Sotatercept in PAH: Safety Signals from Real-World Data

  • Contributing to Scalp Health with an Advanced Shampoo Formulation
    Practical Dermatology

    Contributing to Scalp Health with an Advanced Shampoo Formulation

advertisement

Clinical Practice

  • Aligning Medical and Patient Goals in IBD Treatment
    GI Insights

    Aligning Medical and Patient Goals in IBD Treatment

  • Diet-Microbiome Links Diverge in Crohn’s Disease and Ulcerative Colitis
    GI Insights

    Diet-Microbiome Links Diverge in Crohn’s Disease and Ulcerative Colitis

  • Spotlight on B7-H3 ES-SCLC: Applying ADC Evidence in Real-World Practice
    CME/CE In-Person & Virtual Event

    December 5, 2026
    Scottsdale, Arizona

    Spotlight on B7-H3 ES-SCLC: Applying ADC Evidence in Real-World Practice

  • Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes
    CME/CE

    Continuous Glucose and Ketone Monitoring: Making Smarter Decisions in Diabetes

    1.00 credits
  • APOC3 Inhibition in FCS and Severe Hypertriglyceridemia
    Cardiology

    APOC3 Inhibition in FCS and Severe Hypertriglyceridemia

  • From Episode to Empowerment
    MinuteCE®

    From Episode to Empowerment

    1.00 program credits
advertisement

Doctors Lounge

  • Advancing ATTR-CM Identification: Early Findings from TRACE-AI
    Heart Matters

    Advancing ATTR-CM Identification: Early Findings from TRACE-AI

  • Exploring AI-Powered ATTR-CM Detection
    Heart Matters

    Exploring AI-Powered ATTR-CM Detection

  • Inside Medical Affairs: MSL Insights on AI, Strategy, and Impact
    MAPSChats

    Inside Medical Affairs: MSL Insights on AI, Strategy, and Impact

  • Collaboration in Medical Affairs: Increasing Value and Impact
    MAPSChats

    Collaboration in Medical Affairs: Increasing Value and Impact

  • Turning Insight into Action: The Expanding Role of Medical Affairs
    MAPSChats

    Turning Insight into Action: The Expanding Role of Medical Affairs

  • Trust in MSLs: What Physicians Value Most
    MAPSChats

    Trust in MSLs: What Physicians Value Most

advertisement

CME

  • Individualizing Management Strategies for PSVT: Incorporating Patient Preference
    MinuteCE®

    Individualizing Management Strategies for PSVT: Incorporating Patient Preference

    1.00 program credits
  • Choosing the Right Therapy for Patients With PSVT
    MinuteCE®

    Choosing the Right Therapy for Patients With PSVT

    1.00 program credits
  • Ambulatory Monitoring Approaches for PSVT: Which One and When?
    MinuteCE®

    Ambulatory Monitoring Approaches for PSVT: Which One and When?

    1.00 program credits
  • Applying Best Practices in the Diagnosis of PSVT
    MinuteCE®

    Applying Best Practices in the Diagnosis of PSVT

    1.00 program credits
  • Recognizing ARIA Before Symptoms Appear
    MinuteCE®

    Recognizing ARIA Before Symptoms Appear

    0.50 program credits
  • Who Is Ready for Amyloid-Targeting Therapy?
    MinuteCE®

    Who Is Ready for Amyloid-Targeting Therapy?

    0.50 program credits
advertisement

Industry Feature

  • Beyond the Liver: The Cardiometabolic Impact of MASLD
    Medical Industry Feature

    Beyond the Liver: The Cardiometabolic Impact of MASLD

  • Beyond the Scale: Reducing the Risk of Obesity Complications
    Medical Industry Feature

    Beyond the Scale: Reducing the Risk of Obesity Complications

  • Uncovering Metabolic Connections: Obesity, MASLD, and Heart Disease
    Medical Industry Feature

    Uncovering Metabolic Connections: Obesity, MASLD, and Heart Disease

  • R/R LBCL: A Practical Guide to CAR T Referral and Coordination
    Project Oncology®

    R/R LBCL: A Practical Guide to CAR T Referral and Coordination

  • Centanafadine for Management of Executive Dysfunction and Emotional Dysregulati…
    Innovations In Medicine

    Centanafadine for Management of Executive Dysfunction and Emotional Dysregulation in Adults with ADHD

  • Taking Action in Friedreich Ataxia From Diagnosis to Treatment
    Medical Industry Feature

    Taking Action in Friedreich Ataxia From Diagnosis to Treatment

Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free